INSIGHTS ON CLINICAL TRIAL DESIGN

• SCOPE 2026 In The Rear-View Mirror

  Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

• Clinical Trials Need To Take The Whole Patient Into Account

  Explore how inclusivity in clinical trials needs to encompass the whole patient, taking into account factors like race, sex, age, ethnicity, sexual orientation, and physical abilities or qualities.

• At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights

  Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

• The Next Frontier In Early Phase Oncology Trials

  This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.

• Developing Community-Based And Trial-Naïve Sites: The Real ROI

  9/9/2025

  Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.

• Digital Physical Activity Measures In Phase 3 Immunology Trials

  2/25/2025

  Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

• Accelerate Drug Development With Master Protocols

  5/15/2025

  Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

• The Implications Of Semaglutide's Connect To Increased Risk Of NAION

  2/18/2025

  Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).

• Why Do Clinical Trials Cost So Much? Looking Beyond The Obvious

  6/29/2026

  The true cost of research goes beyond budgets to design, data, and execution inefficiencies. Streamlining processes and early decisions reduces delays, controls costs, and improves study quality.